{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T03:53:31Z","timestamp":1788666811242,"version":"build-2803163510"},"reference-count":68,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Center, Poland","award":["2024\/08\/X\/NZ5\/00659"],"award-info":[{"award-number":["2024\/08\/X\/NZ5\/00659"]}]},{"name":"National Science Center, Poland","award":["2022\/45\/B\/NZ6\/02336"],"award-info":[{"award-number":["2022\/45\/B\/NZ6\/02336"]}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["PBmb163"],"award-info":[{"award-number":["PBmb163"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010621","name":"Medical University of Lublin","doi-asserted-by":"crossref","award":["DS640"],"award-info":[{"award-number":["DS640"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Primary glomerulopathies share common immune dysregulation but differ in their predominant pathways. We compared immune checkpoint profiles in minimal change disease (MCD) and membranous nephropathy (MN) with those in healthy volunteers (HV). In a cohort of 90 individuals (MCD, n = 30; MN, n = 30; HV, n = 30), we performed multiparameter flow cytometry of PBMCs to assess the expression of PD-1\/PD-L1, CTLA-4\/CD86, and CD200\/CD200R on CD4+and CD8+ T cells, CD19+ B cells, and natural killer cells (NK cells). ELISA measured serum soluble checkpoint concentrations, and transcript levels in PBMCs were measured by qPCR. Nonparametric statistics and ROC analysis were used. In MCD, a skewed T cell pattern was observed, characterized by dominant expression of PD-1 and CTLA-4, whereas in MN, a humoral predominance was observed with higher PD-L1 expression and attenuated CD200\/CD200R axis. Across diseases, expression profiles and correlations between markers differed between HV and between MCD and MN. Soluble checkpoints (sPD-1, sPD-L1, sCD200, sCD200R) showed potential discriminatory value for GN compared to HV and for differentiating MCD from MN in ROC analyses. These findings indicate that the mechanisms maintaining immune tolerance in primary GN are standard but pathway-specific, consistent with the dominant immunological component of each disease. A significant implication of this study is the need to conduct tissue-level studies to confirm clinical utility and provide insights into personalized immunomodulatory strategies targeting PD-1\/PD-L1, CTLA-4\/CD86, and CD200\/CD200R.<\/jats:p>","DOI":"10.3390\/ijms262311371","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T08:50:20Z","timestamp":1764060620000},"page":"11371","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immune Checkpoint Signatures in Minimal Change Disease and Membranous Nephropathy: Divergent Pathways of a Shared Imbalance"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7121-1396","authenticated-orcid":false,"given":"Sebastian","family":"Mertowski","sequence":"first","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, Chod\u017aki 4a Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-6659","authenticated-orcid":false,"given":"Paulina","family":"Mertowska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, Chod\u017aki 4a Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Czosnek","sequence":"additional","affiliation":[{"name":"Student Research Group of Experimental Immunology, Medical University of Lublin, Chod\u017aki 4a Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Smarz-Widelska","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Cardinal Stefan Wyszynski Provincial Hospital in Lublin, Al. Kra\u015bnicka Street, 20-718 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Za\u0142uska","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Medical University of Lublin, 8 Jaczewskiego Street, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Grywalska","sequence":"additional","affiliation":[{"name":"Department of Experimental Immunology, Medical University of Lublin, Chod\u017aki 4a Street, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Roman, M., and Nowicki, M. (2024). Detailed Pathophysiology of Minimal Change Disease: Insights into Podocyte Dysfunction, Immune Dysregulation, and Genetic Susceptibility. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212174"},{"key":"ref_2","first-page":"e91728","article-title":"Patterns of Glomerular Injury: Histopathological Classification and Clinical Correlation","volume":"17","author":"Qasim","year":"2025","journal-title":"Cureus"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wendt, R., Sobhani, A., Diefenhardt, P., Trappe, M., and V\u00f6lker, L.A. (2024). An Updated Comprehensive Review on Diseases Associated with Nephrotic Syndromes. Biomedicines, 12.","DOI":"10.20944\/preprints202409.0619.v1"},{"key":"ref_4","unstructured":"Zamora, G., and Pearson-Shaver, A.L. (2025). Minimal Change Disease. StatPearls, StatPearls Publishing."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal Change Disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fped.2016.00032","article-title":"Pathology of Podocytopathies Causing Nephrotic Syndrome in Children","volume":"4","author":"Ranganathan","year":"2016","journal-title":"Front. Pediatr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.15171\/jnp.2017.32","article-title":"Impact of \u03a4h1 and \u03a4h2 Cytokines in the Progression of Idiopathic Nephrotic Syndrome Due to Focal Segmental Glomerulosclerosis and Minimal Change Disease","volume":"6","author":"Stangou","year":"2017","journal-title":"J. Nephropathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fmed.2018.00170","article-title":"Molecular and Cellular Mechanisms for Proteinuria in Minimal Change Disease","volume":"5","author":"Bertelli","year":"2018","journal-title":"Front. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12519-015-0003-9","article-title":"Pathogenesis of Childhood Idiopathic Nephrotic Syndrome: A Paradigm Shift from T-Cells to Podocytes","volume":"11","author":"Kaneko","year":"2015","journal-title":"World J. Pediatr."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Maslyennikov, Y., B\u0103rar, A.A., Rusu, C.C., Potra, A.R., Tirinescu, D., Ticala, M., Urs, A., Pralea, I.E., Iuga, C.A., and Moldovan, D.T. (2025). The Spectrum of Minimal Change Disease\/Focal Segmental Glomerulosclerosis: From Pathogenesis to Proteomic Biomarker Research. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26062450"},{"key":"ref_11","unstructured":"Tapia, C., and Bashir, K. (2025). Nephrotic Syndrome. StatPearls, StatPearls Publishing."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Bogdanovi\u0107, L., Babi\u0107, I., Prvanovi\u0107, M., Mija\u010d, D., Mladenovi\u0107-Markovi\u0107, A., Popovi\u0107, D., and Bogdanovi\u0107, J. (2025). Uncommon Factors Leading to Nephrotic Syndrome. Biomedicines, 13.","DOI":"10.3390\/biomedicines13081907"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000517626","article-title":"Steroid Minimization in Adults with Minimal Change Disease","volume":"1","author":"Koirala","year":"2021","journal-title":"Glomerular Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3233\/JND-200556","article-title":"Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy","volume":"8","author":"Quattrocelli","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Dong, Y., Xu, H., and Tang, D. (2025). Membranous Nephropathy Target Antigens Display Podocyte-Specific and Non-Specific Expression in Healthy Kidneys. Genes, 16.","DOI":"10.3390\/genes16030241"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous Nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102976","DOI":"10.1016\/j.autrev.2021.102976","article-title":"Course Monitoring of Membranous Nephropathy: Both Autoantibodies and Podocytes Require Multidimensional Attention","volume":"21","author":"Liu","year":"2022","journal-title":"Autoimmun. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"611317","DOI":"10.3389\/fmed.2020.611317","article-title":"Secondary Membranous Nephropathy. A Narrative Review","volume":"7","author":"Moroni","year":"2020","journal-title":"Front. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.matbio.2016.07.008","article-title":"Basement Membranes and Autoimmune Diseases","volume":"57\u201358","author":"Foster","year":"2017","journal-title":"Matrix Biol."},{"key":"ref_20","unstructured":"Alok, A., and Yadav, A. (2025). Membranous Nephropathy. StatPearls, StatPearls Publishing."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12775\/QS.2023.13.01.007","article-title":"Primary Membranous Nephropathy\u2014What Do We Know Today?","volume":"13","author":"Wais","year":"2023","journal-title":"Qual. Sport"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Smarz-Widelska, I., Choj\u0119ta, D., and Kozio\u0142, M.M. (2022). The Role of Anti-PLA2R and Anti-THSD7A Antibodies in the Pathogenesis and Diagnostics of Primary Membranous Nephropathy: A Review of Current Knowledge for Clinical Practice. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19095301"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.2215\/CJN.01460217","article-title":"Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy","volume":"12","author":"Wang","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"593288","DOI":"10.3389\/fimmu.2021.593288","article-title":"Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy","volume":"12","author":"Tesar","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Islam, S., Janoudi, G., Bryan, M., Perras, C., Jabr, M., Haines, A., Assasi, N., Boucher, J., Hafizi, D., and Lafleur, P. (2022). Rituximab for the Treatment of Primary Membranous Nephropathy: CADTH Health Technology Review, Canadian Agency for Drugs and Technologies in Health. CADTH Health Technology Review.","DOI":"10.51731\/cjht.2022.313"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1110355","DOI":"10.3389\/fneph.2023.1110355","article-title":"Treatment of Membranous Nephropathy: Perspectives on Current and Future Therapies","volume":"3","author":"Shah","year":"2023","journal-title":"Front. Nephrol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Del Vecchio, L., Peiti, S., Pucci Bella, G., and Locatelli, F. (2025). SGLT2 Inhibitors in Glomerulonephritis: Beyond Nephroprotection?. J. Clin. Med., 14.","DOI":"10.3390\/jcm14103533"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/s12882-024-03784-8","article-title":"Observational Study of Immunosuppressive Treatment Patterns and Outcomes in Primary Membranous Nephropathy: A Multicenter Retrospective Analysis","volume":"25","author":"Artan","year":"2024","journal-title":"BMC Nephrol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41577-022-00816-y","article-title":"Glomerulonephritis: Immunopathogenesis and Immunotherapy","volume":"23","author":"Anders","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46439\/immunol.4.032","article-title":"Update on Glomerulonephritis: How to Classify and How to Treat","volume":"4","author":"Klaus","year":"2025","journal-title":"J. Cell. Mol. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1335936","DOI":"10.3389\/fimmu.2023.1335936","article-title":"Understanding the Podocyte Immune Responses in Proteinuric Kidney Diseases: From Pathogenesis to Therapy","volume":"14","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40348-023-00157-3","article-title":"New Insights into the Immune Functions of Podocytes: The Role of Complement","volume":"10","author":"Bruno","year":"2023","journal-title":"Mol. Cell. Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e614","DOI":"10.1002\/mco2.614","article-title":"Membranous Nephropathy: Pathogenesis and Treatments","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ekir.2020.07.028","article-title":"A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti\u2013Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients","volume":"5","author":"Cantarelli","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Strizzi, C.T., Ambrogio, M., Zanoni, F., Bonerba, B., Bracaccia, M.E., Grandaliano, G., and Pesce, F. (2024). Epitope Spreading in Immune-Mediated Glomerulonephritis: The Expanding Target. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252011096"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"6281054","DOI":"10.1155\/2018\/6281054","article-title":"Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management","volume":"2018","author":"Pozdzik","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Mertowski, S., Mertowska, P., Czosnek, M., Smarz-Widelska, I., Za\u0142uska, W., and Grywalska, E. (2025). Checkpoint Imbalance in Primary Glomerulopathies: Comparative Insights into IgA Nephropathy and Membranoproliferative Glomerulonephritis. Cells, 14.","DOI":"10.3390\/cells14191551"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.kint.2024.09.017","article-title":"Diagnosis and Management of Immune Checkpoint Inhibitor\u2013Associated Nephrotoxicity: A Position Statement from the American Society of Onco-Nephrology","volume":"107","author":"Herrmann","year":"2025","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"111ra120","DOI":"10.1126\/scitranslmed.3003130","article-title":"The PDL1-PD1 Axis Converts Human Th1 Cells Into Regulatory T Cells","volume":"3","author":"Amarnath","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.ekir.2023.06.001","article-title":"Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors","volume":"8","author":"Benyahia","year":"2023","journal-title":"Kidney Int. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"101914","DOI":"10.1016\/j.mcp.2023.101914","article-title":"Evaluation of the Immune Checkpoint Factors in Idiopathic Membranous Nephropathy","volume":"69","author":"Motavalli","year":"2023","journal-title":"Mol. Cell. Probes"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00005-017-0485-3","article-title":"The PD-1\/PD-L1 Inhibitory Pathway Is Altered in Primary Glomerulonephritides","volume":"66","author":"Grywalska","year":"2018","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Grywalska, E., Smarz-Widelska, I., Korona-G\u0142owniak, I., Mertowski, S., Gosik, K., Hymos, A., Ludian, J., Nied\u017awiedzka-Rystwej, P., Roli\u0144ski, J., and Za\u0142uska, W. (2020). PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218001"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/ndt\/gft381","article-title":"The CTLA-4 +49GG Genotype Is Associated with Susceptibility for Nephrotic Kidney Diseases","volume":"28","author":"Spink","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/ndt\/gfaf030","article-title":"T Cell Costimulatory Blockade Ameliorates Induction of Experimental Membranous Nephropathy Potentially through T-Helper 17 Cell Suppression in the Kidney","volume":"40","author":"Chung","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Ponticelli, C. (2025). Membranous Nephropathy. J. Clin. Med., 14.","DOI":"10.3390\/jcm14030761"},{"key":"ref_47","first-page":"9607","article-title":"The CD200\/CD200R Mechanism in Mesenchymal Stem Cells\u2019 Regulation of Dendritic Cells","volume":"13","author":"Zhao","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00011-014-0716-6","article-title":"Decreased CD200R Expression on Monocyte-Derived Macrophages Correlates with Th17\/Treg Imbalance and Disease Activity in Rheumatoid Arthritis Patients","volume":"63","author":"Gao","year":"2014","journal-title":"Inflamm. Res."},{"key":"ref_49","first-page":"682168","article-title":"CD200:CD200R-Mediated Regulation of Immunity","volume":"2012","author":"Gorczynski","year":"2012","journal-title":"Int. Sch. Res. Not."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e17006","DOI":"10.1097\/MD.0000000000017006","article-title":"Pre-Transplant CD200 and CD200R1 Concentrations Are Associated with Post-Transplant Events in Kidney Transplant Recipients","volume":"98","author":"Oweira","year":"2019","journal-title":"Medicine"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/ndt\/gfw467","article-title":"Adverse Kidney Effects of Epidermal Growth Factor Receptor Inhibitors","volume":"32","author":"Izzedine","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1053\/j.ajkd.2019.04.016","article-title":"Renal Vasculitis and Pauci-Immune Glomerulonephritis Associated With Immune Checkpoint Inhibitors","volume":"74","author":"Gallan","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1080\/0886022X.2022.2147439","article-title":"Glomerular Diseases after Immune Checkpoint Inhibitors Use: What Do We Know so Far?","volume":"44","author":"He","year":"2022","journal-title":"Ren. Fail."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Qu, L., and Jiao, B. (2023). The Interplay between Immune and Metabolic Pathways in Kidney Disease. Cells, 12.","DOI":"10.3390\/cells12121584"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e20211004","DOI":"10.1084\/jem.20211004","article-title":"P2RY8 Variants in Lupus Patients Uncover a Role for the Receptor in Immunological Tolerance","volume":"219","author":"He","year":"2022","journal-title":"J. Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.trsl.2024.05.004","article-title":"Immune Checkpoint Activity Exacerbate Renal Interstitial Fibrosis Progression by Enhancing PD-L1 Expression in Renal Tubular Epithelial Cells","volume":"271","author":"Zhang","year":"2024","journal-title":"Transl. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"102308","DOI":"10.1016\/j.jaut.2019.102308","article-title":"Autoantigens PLA2R and THSD7A in Membranous Nephropathy Share a Common Epitope Motif in the N-Terminal Domain","volume":"106","author":"Fresquet","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1681\/ASN.2017020178","article-title":"PLA2R and THSD7A: Disparate Paths to the Same Disease?","volume":"28","author":"Beck","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The Anti-PLA2R Antibody in Membranous Nephropathy: What We Know and What Remains a Decade after Its Discovery","volume":"96","author":"Fresquet","year":"2019","journal-title":"Kidney Int."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00467-010-1676-x","article-title":"Minimal Change Disease: A \u201cTwo-Hit\u201d Podocyte Immune Disorder?","volume":"26","author":"Shimada","year":"2011","journal-title":"Pediatr. Nephrol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.krcp.2015.03.003","article-title":"Nonimmunologic Targets of Immunosuppressive Agents in Podocytes","volume":"34","author":"Yoo","year":"2015","journal-title":"Kidney Res. Clin. Pract."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1548234","DOI":"10.3389\/fimmu.2025.1548234","article-title":"Deciphering T-Cell Exhaustion in the Tumor Microenvironment: Paving the Way for Innovative Solid Tumor Therapies","volume":"16","author":"Nair","year":"2025","journal-title":"Front. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"665629","DOI":"10.3389\/fimmu.2021.665629","article-title":"Helper T Cells in Idiopathic Membranous Nephropathy","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"So, B.Y.F., Yap, D.Y.H., and Chan, T.M. (2021). B Cells in Primary Membranous Nephropathy: Escape from Immune Tolerance and Implications for Patient Management. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413560"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuroscience.2018.10.030","article-title":"Role of the CD200-CD200R Axis During Homeostasis and Neuroinflammation","volume":"405","author":"Manich","year":"2019","journal-title":"Neuroscience"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Zdravkova, I., Tilkiyan, E., Bozhkova, D., Kuskunov, T., Ronchev, Y., and Kirilov, B. (2025). Hypothetical Pathogenetic Model of Membranous Nephropathy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26052206"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1102036","DOI":"10.3389\/fimmu.2022.1102036","article-title":"Editorial: Primary Membranous Nephropathy","volume":"13","author":"Infantino","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_68","first-page":"23","article-title":"Membranous Nephropathy: Genetics, Antigens and Antibodies","volume":"2","author":"Courville","year":"2024","journal-title":"Genet. Clin. Genom."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11371\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:19:21Z","timestamp":1764220761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":68,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311371"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311371","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}